Drug Formulary Review articles from July 2006

Drug Formulary Review archives from July 2006

Web-based calculator reduces errors, improves pediatric infusions and chemo.
July 1, 2006... Web-based calculator reduces errors, improves pediatric infusions and chemo Research conducted at the Johns Hopkins University School of Medicine has found that use of a web-based calculator significantly reduces the total number of errors...

Clinical pharmacists involved in many ICUs.
July 1, 2006... Clinical pharmacists involved in many ICUs Clinical pharmacists are directly involved as caregivers in nearly two-thirds of U.S. ICUs. Research conducted by Robert MacLaren, PharmD, an assistant professor at the University of Colorado...

ED drug storage location influences prescribing.
July 1, 2006... ED drug storage location influences prescribing Adding drugs to an emergency department (ED) automated medication management system (ED AMMS) influences the frequency with which physicians prescribe them, according to a study from the...

News Briefs.(lonidamine trial suspended )(Paxil and suicide risk)
July 1, 2006... FDA suspends clinical trial of lonidamine for BPH FDA has suspended a Phase 3 trial of Threshold Pharmaceuticals' lonidamine for treating benign prostatic hypertrophy (BPH) after six participants showed liver problems. The agency said...

New FDA Approvals.
July 1, 2006... The FDA recently approved these drugs: • Remicade (infliximab) was approved to treat children with active Crohn's disease. FDA said Centocor's infliximab is a genetically engineered monoclonal antibody that reduces inflammation by...

Drug Criteria & Outcomes: NeoProfen Formulary Evaluation.
July 1, 2006... Drug Criteria & Outcomes NeoProfen Formulary Evaluation By Reena Patel, PharmD Candidate, Huntsville (AL) Hospital NeoProfen® (ibuprofen lysine injection), manufactured and distributed by Ovation Pharmaceuticals Indocin IV...

CE objectives/questions.
July 1, 2006... CE objectives/questions This CE program will improve participants' ability to: *Compare the clinical efficacy and safety of one therapeutic agent over another used in the same setting. *Assess clinical trial data and explain how...